Next Article in Journal
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
Previous Article in Journal
Predictors of Symptomatic Venous Thromboembolism in Patients with Soft Tissue Sarcoma in the Lower Extremity
Previous Article in Special Issue
Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies
 
 
Review

Article Versions Notes

Cancers 2023, 15(1), 313; https://doi.org/10.3390/cancers15010313
Action Date Notes Link
article html file updated 3 September 2025 20:35 CEST Update https://www.mdpi.com/2072-6694/15/1/313/html
article html file updated 6 March 2023 20:27 CET Update -
article html file updated 1 March 2023 07:30 CET Update -
article html file updated 4 January 2023 02:02 CET Update -
article pdf uploaded. 4 January 2023 02:01 CET Updated version of record https://www.mdpi.com/2072-6694/15/1/313/pdf
article xml uploaded. 4 January 2023 02:01 CET Update https://www.mdpi.com/2072-6694/15/1/313/xml
article xml file uploaded 4 January 2023 02:01 CET Update -
article html file updated 3 January 2023 09:27 CET Original file -
article pdf uploaded. 3 January 2023 09:26 CET Version of Record https://www.mdpi.com/2072-6694/15/1/313/pdf-vor
article xml uploaded. 3 January 2023 09:26 CET Update -
article xml file uploaded 3 January 2023 09:26 CET Original file -
Back to TopTop